Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters.

BACKGROUND Nephrocalcinosis (NC) in preterm neonates has been described frequently, and small-scale studies suggest an unfavorable effect on renal function. The etiologic factors have not yet been fully clarified. We performed a prospective observational study to identify factors that influence the development of NC. METHODS The study population consisted of 215 preterm neonates with a gestational age <32 weeks. Clinical characteristics and intake in the first four weeks of calcium, phosphorus, vitamin D, protein, and ascorbic acid were noted. Serum calcium, phosphate, vitamin D, magnesium, uric acid, creatinine, urea and urinary calcium, phosphate, oxalate, citrate, magnesium, uric acid, and creatinine were assessed at four weeks of age and at term. Renal ultrasonography (US) was performed at four weeks and at term. At term was defined as a postconceptional age of 38 to 42 weeks. RESULTS NC was diagnosed by means of US in 33% at four weeks and in 41% at term. Patients with NC at four weeks had a significantly higher mean intake of calcium (P < 0.05), phosphorus (P < 0.05), and ascorbic acid (P < 0.01) than patients without NC. They had a higher mean serum calcium (2.55 vs. 2.46 mmol/L, P < 0.01) and a higher mean urinary calcium/creatinine ratio (2.6 vs. 2.1 mmol/mmol, P < 0.05). Patients with NC at term had a lower birth weight (1142 vs. 1260 g, P < 0.05) and a lower gestational age (28.8 vs. 29.4 weeks, P < 0.05), were treated significantly longer with furosemide, dexamethasone, theophylline, and thiazides, developed chronic lung disease more frequently (40 vs. 16%, P < 0.001), and had a higher mean urinary calcium/creatinine ratio (2.7 vs. 2.3 mmol/mmol, P < 0.05) and a lower mean urinary citrate/calcium ratio (1.1 vs. 1.7 mmol/mmol, P = 0.005). CONCLUSIONS NC develops as a result of an imbalance between stone-inhibiting and stone-promoting factors. A high intake of calcium, phosphorus, and ascorbic acid, a low urinary citrate/calcium ratio, a high urinary calcium/creatinine ratio, immaturity, and medication to prevent or treat chronic lung disease with hypercalciuric side effects appear to contribute to the high incidence of NC in preterm neonates.

[1]  D. Kok,et al.  Risk factors for crystallization in the nephron: the role of renal development. , 1999, Journal of the American Society of Nephrology : JASN.

[2]  P. Lanning,et al.  Nephrocalcinosis in full-term infants receiving furosemide treatment for congestive heart failure: a study of the incidence and 2-year follow up , 1999, European Journal of Pediatrics.

[3]  P. Lanning,et al.  Incidence, ultrasonic patterns and resolution of nephrocalcinosis in very low birthweight infants , 1999, Acta paediatrica.

[4]  J. Sonntag,et al.  [Effect of dexamethasone and spironolactone therapy in calcium and phosphate homeostasis in premature infants with a birth weight under 1,500 g]. , 1998, Klinische Padiatrie.

[5]  N. Blau,et al.  Influence of nutrition on urinary oxalate and calcium in preterm and term infants , 1997, Pediatric Nephrology.

[6]  V. Zanardo,et al.  Non‐furosemide‐related renal calcifications in premature infants with bronchopulmonary dysplasia , 1997, Acta paediatrica Japonica : Overseas edition.

[7]  G. Braden,et al.  Effect of diuretics on urinary oxalate, calcium, and sodium excretion in very low birth weight infants. , 1997, Pediatrics.

[8]  C. Jones,et al.  Renal calcification in preterm infants: follow up at 4–5 years , 1997, Archives of disease in childhood. Fetal and neonatal edition.

[9]  J. Jarosz,et al.  The incidence of transient renal medullary hyperechogenicity in neonatal ultrasound examination. , 1997, The British journal of radiology.

[10]  R. Starinsky,et al.  Increased renal medullary echogenicity in neonates , 1995, Pediatric Radiology.

[11]  D. Nyberg,et al.  Renal calcification: a complication of dexamethasone therapy in preterm infants with bronchopulmonary dysplasia. , 1995, Journal of perinatology : official journal of the California Perinatal Association.

[12]  S. Atkinson,et al.  Dexamethasone treatment impairs calcium regulation and reduces bone mineralization in infant pigs. , 1995, The American journal of clinical nutrition.

[13]  M. Karlowicz,et al.  Nephrocalcinosis in very low birth weight neonates: sonographic patterns, histologic characteristics, and clinical risk factors. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[14]  P. Davis,et al.  Effect of high dose vitamin C on urinary oxalate levels. , 1994, The Journal of urology.

[15]  N. Blau,et al.  Urinary saturation and nephrocalcinosis in preterm infants: effect of parenteral nutrition. , 1993, Archives of disease in childhood.

[16]  T. Stukel,et al.  Normal values for random urinary calcium to creatinine ratios in infancy. , 1993, The Journal of pediatrics.

[17]  A. Lucas Nutritional Needs of the Preterm Infant: Scientific Basis and Practical Guidelines , 1993 .

[18]  M. E. Katz,et al.  Nephrocalcinosis in very low birth weight neonates: family history of kidney stones and ethnicity as independent risk factors. , 1993, The Journal of pediatrics.

[19]  T. Riebel,et al.  Transient renal medullary hyperechogenicity in ultrasound studies of neonates: Is it a normal phenomenon and what are the causes? , 1993, Journal of clinical ultrasound : JCU.

[20]  Arthur D. Smith,et al.  Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. , 1992, The Journal of urology.

[21]  U. Alon,et al.  Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years. , 1992, The Journal of pediatrics.

[22]  J. Simpson,et al.  Effects of therapy in X-linked hypophosphatemic rickets. , 1991, The New England journal of medicine.

[23]  J. Strife,et al.  Hyperechoic renal medullary pyramids in infants and children. , 1991, Radiology.

[24]  G. A. Rose,et al.  Urinary oxalate and glycolate excretion and plasma oxalate concentration. , 1991, Archives of disease in childhood.

[25]  R. Cooke,et al.  The incidence of renal calcification in preterm infants. , 1991, Archives of disease in childhood.

[26]  S. Jéquier,et al.  Echogenic renal pyramids in children , 1991, Journal of clinical ultrasound : JCU.

[27]  J. Brodehl,et al.  Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets , 1990, The Lancet.

[28]  Gaetano Chirico,et al.  Increased renal echogenicity in the neonate. , 1990, Early human development.

[29]  R. Vileisis Furosemide effect on mineral status of parenterally nourished premature neonates with chronic lung disease. , 1990, Pediatrics.

[30]  A. Ohlsson,et al.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. , 1988, Pediatrics.

[31]  C. Ahlfors,et al.  Renal calcification in preterm infants: pathophysiology and long-term sequelae. , 1988, The Journal of pediatrics.

[32]  S. Atkinson,et al.  Mineral excretion in premature infants receiving various diuretic therapies. , 1988, The Journal of pediatrics.

[33]  H. Modanlou,et al.  Renal calcification incidence in very low birth weight infants. , 1988, Pediatrics.

[34]  J. Guignard,et al.  Renal function in the tiny, premature infant. , 1986, Clinics in perinatology.

[35]  A. Aperia,et al.  Renal excretion of calcium and phosphate in preterm and term infants. , 1985, The Journal of pediatrics.

[36]  U. Alon,et al.  Nephrocalcinosis: detection by ultrasonography. , 1983, Pediatrics.

[37]  S. Khan,et al.  Renal calcifications: a complication of long-term furosemide therapy in preterm infants. , 1982, Pediatrics.

[38]  E. Yendt,et al.  Prevention of calcium stones with thiazides. , 1978, Kidney international.

[39]  Literature abstracts , 2004, Pediatric Nephrology.

[40]  B. Cramer,et al.  Nephrocalcinosis in rabbits – correlation of ultrasound, computed tomography, pathology and renal function , 1998, Pediatric Radiology.

[41]  O. Miyake,et al.  High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis , 1998, Urological Research.

[42]  I. Højgaard Crystallisation of calcium phosphate and calcium oxalate in solutions simulating the composition at different levels of the nephron , 1998 .

[43]  A. Coussement,et al.  Nephrocalcinosis and prematurity: importance of urate and oxalate excretion. , 1995, Nephron.

[44]  A. Guglielmi,et al.  Methylxanthines increase renal calcium excretion in preterm infants. , 1995, Biology of the neonate.

[45]  B. Sela,et al.  Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets. , 1993, Nephron.

[46]  A. Cupisti,et al.  Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males. , 1992, Nephron.

[47]  S. Mendoza,et al.  Decreased urinary citrate in premature infants with lung disease. , 1990, Child nephrology and urology.

[48]  T. Koivula,et al.  Urinary citrate excretion in patients with urolithiasis and normal subjects. , 1989, European urology.